2-[(1-methyl-6-oxopyridazin-3-yl)methyl]guanidine;hydrochloride
C7H12ClN5O — CID 166631229
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[(1-methyl-6-oxopyridazin-3-yl)methyl]guanidine;hydrochloride
2-[(1-methyl-6-oxopyridazin-3-yl)methyl]guanidine;hydrochloride (PubChem CID 166631229) has the molecular formula C7H12ClN5O and a molecular weight of 217.66 g/mol. Its IUPAC name is 2-[(1-methyl-6-oxopyridazin-3-yl)methyl]guanidine;hydrochloride.
Molecular Properties
| Compound Name | 2-[(1-methyl-6-oxopyridazin-3-yl)methyl]guanidine;hydrochloride |
|---|---|
| PubChem CID | 166631229 |
| Molecular Formula | C7H12ClN5O |
| Molecular Weight | 217.66 g/mol |
| Exact Mass | 217.07 |
| IUPAC Name | 2-[(1-methyl-6-oxopyridazin-3-yl)methyl]guanidine;hydrochloride |
| SMILES | Cl.Cn1nc(CN=C(N)N)ccc1=O |
| InChI | InChI=1S/C7H11N5O.ClH/c1-12-6(13)3-2-5(11-12)4-10-7(8)9;/h2-3H,4H2,1H3,(H4,8,9,10);1H |
| InChIKey | VAFZJSKQIILFBJ-UHFFFAOYSA-N |
| XLogP | -1.02 |
| TPSA | 99.29 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 14 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 217.66 |
| LogP ≤ 5 | -1.02 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 166631229 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.